AMPK and Cisplatin Resistance

Shree Bose – USA

Each year, over 21,000 women are diagnosed with ovariancancer – the 5th leading cause of cancer-related deaths in women in the United States. One of the most common drugs usedin ovarian cancer chemotherapy is cisplatin, …

a platinum-based chemotherapy treatment. While the drug affects ordinary cells, the significantly higher replication frequency of cancer cells causes cisplatin to have a greater impact in malignant cells. However, cancer cells often develop resistance to cisplatin, rendering the treatment ineffective. To improve the efficiency of cisplatin treatment, this research sought to determine whether AMP kinase, an energy protein of cell, plays a role in the development of cisplatin resistance. Studies with various techniques showed a significant difference on cell death caused by cisplatin insensitive and resistant ovarian cancer cells when AMPK was inhibited,suggesting that AMPK plays a role in the development of resistance. This work,in addition to offering a new treatment regime, also furthers our understanding of ovarian cancer and cancers in general.

Google Science Fair